Oscar D. Bello

ORCID: 0000-0001-5701-8365
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cellular transport and secretion
  • Lipid Membrane Structure and Behavior
  • Neuroscience and Neuropharmacology Research
  • Ion channel regulation and function
  • Biotin and Related Studies
  • RNA regulation and disease
  • Calcium signaling and nucleotide metabolism
  • Biochemical and Structural Characterization
  • RNA Research and Splicing
  • Signaling Pathways in Disease
  • Microtubule and mitosis dynamics
  • Pancreatic function and diabetes
  • Erythrocyte Function and Pathophysiology
  • RNA modifications and cancer
  • Neurological diseases and metabolism
  • COVID-19 Clinical Research Studies
  • Mitochondrial Function and Pathology
  • Amino Acid Enzymes and Metabolism
  • Receptor Mechanisms and Signaling
  • Pediatric Hepatobiliary Diseases and Treatments
  • Genetic Neurodegenerative Diseases
  • Vaccine Coverage and Hesitancy
  • Endoplasmic Reticulum Stress and Disease
  • SARS-CoV-2 and COVID-19 Research
  • Myasthenia Gravis and Thymoma

Consejo Nacional de Investigaciones Científicas y Técnicas
2012-2023

Instituto de Histología y Embriología de Mendoza
2012-2023

Yale University
2015-2020

University College London
2017-2020

National Hospital for Neurology and Neurosurgery
2017-2020

Epilepsy Research UK
2018-2020

Universidad Autónoma Metropolitana
2020

Washington Center
2018

University of Washington
2018

Universidad Nacional de Cuyo
2015-2016

Vincenzo Salpietro Christine L. Dixon Hui Guo Oscar D. Bello Jana Vandrovcová and 95 more Stéphanie Efthymiou Reza Maroofian Gali Heimer Lydie Bürglen Stéphanie Valence Erin Torti Moritz Hacke Julia Rankin Huma Tariq Estelle Colin Vincent Procaccio Pasquale Striano Kshitij Mankad Andreas Lieb Sharon Chen Laura Rosa Pisani Conceição Bettencourt Roope Männikkö Andreea Manole Alfredo Brusco Enrico Grosso Giovanni Battista Ferrero Judith Armstrong-Moron Sophie Guéden Omer Bar‐Yosef Michal Tzadok Kristin G. Monaghan Teresa Santiago‐Sim Richard Person Megan T. Cho Rebecca Willaert Yongjin Yoo Jong‐Hee Chae Yingting Quan Huidan Wu Tianyun Wang Raphael Bernier Kun Xia Alyssa Blesson Mahim Jain Mohammad Mahdi Motazacker Bregje Jaeger Amy L. Schneider Katja Boysen Alison M. Muir Candace T. Myers Ralitza H. Gavrilova Lauren Gunderson Laura Schultz‐Rogers Eric W. Klee David A. Dyment Matthew Osmond Mara Parellada Cloe Llorente Javier González‐Peñas Ángel Carracedo Arie van Haeringen Claudia Ruivenkamp Caroline Nava Delphine Héron Rosaria Nardello Michele Iacomino Carlo Minetti Aldo Skabar Antonella Fabretto Michael G. Hanna Enrico Bugiardini Isabel C. Hostettler Benjamin O’Callaghan Alaa Khan Andrea Cortese Emer O’Connor Wai Y. Yau Thomas Bourinaris Rauan Kaiyrzhanov Viorica Chelban M Madej Maria C. Diana Maria S. Vari Marina Pedemonte Claudio Bruno Ganna Balagura Marcello Scala Chiara Fiorillo Lino Nobili Nancy T. Malintan M. Natalia Zanetti Shyam S. Krishnakumar Gabriele Lignani James E.C. Jepson Paolo Broda Sımona Baldassari Pia Rossi Floriana Fruscione Francesca Madia

Abstract AMPA receptors (AMPARs) are tetrameric ligand-gated channels made up of combinations GluA1-4 subunits encoded by GRIA1-4 genes. GluA2 has an especially important role because, following post-transcriptional editing at the Q607 site, it renders heteromultimeric AMPARs Ca 2+ -impermeable, with a linear relationship between current and trans-membrane voltage. Here, we report heterozygous de novo GRIA2 mutations in 28 unrelated patients intellectual disability (ID) neurodevelopmental...

10.1038/s41467-019-10910-w article EN cc-by Nature Communications 2019-07-12

10.1016/j.ajhg.2019.02.016 article EN cc-by The American Journal of Human Genetics 2019-03-28

Significance Synaptotagmin-1 is the calcium sensor for synchronous neurotransmitter release. It couples influx to soluble N -ethylmaleimide–sensitive factor activating protein receptor (SNARE)-catalyzed fusion, but how this coupling happens unknown. Here, using electron microscopy, we report that cytosolic domain of synaptotagmin can assemble into ring-like oligomers under calcium-free conditions, and these rings disassemble rapidly upon binding. This process suggests a novel speculative...

10.1073/pnas.1415849111 article EN Proceedings of the National Academy of Sciences 2014-09-08

Brown-Vialetto-Van Laere syndrome represents a phenotypic spectrum of motor, sensory, and cranial nerve neuropathy, often with ataxia, optic atrophy respiratory problems leading to ventilator-dependence. Loss-of-function mutations in two riboflavin transporter genes, SLC52A2 SLC52A3, have recently been linked syndrome. However, the genetic frequency, neuropathology downstream consequences are unclear. By screening large cohort 132 patients early-onset severe motor neuropathy we confirmed...

10.1093/brain/awx231 article EN cc-by Brain 2017-08-23

Hormones and neurotransmitters are released through fluctuating exocytotic fusion pores that can flicker open shut multiple times. Cargo release vesicle recycling depend on the fate of pore, which may reseal or dilate irreversibly. Pore nucleation requires zippering between vesicle-associated v-SNAREs target membrane t-SNAREs, but mechanisms governing subsequent pore dilation not understood. Here, we probed single using v-SNARE-reconstituted ~23-nm-diameter discoidal nanolipoprotein...

10.7554/elife.22964 article EN cc-by eLife 2017-03-27

We recently reported that the C2AB portion of Synaptotagmin 1 (Syt1) could self-assemble into Ca2+-sensitive ring-like oligomers on membranes, which potentially regulate neurotransmitter release. Here we report analogous assemble from domains other Syt isoforms (Syt2, Syt7, Syt9) as well related C2 domain containing protein, Doc2B and extended Synaptotagmins (E-Syts). Evidently, circular oligomerization is a general conserved structural aspect many proteins, including Synaptotagmins....

10.7554/elife.17262 article EN cc-by eLife 2016-07-19

Objective To identify disease‐causing variants in autosomal recessive axonal polyneuropathy with optic atrophy and provide targeted replacement therapy. Methods We performed genome‐wide sequencing, homozygosity mapping, segregation analysis for novel gene discovery. used circular dichroism to show secondary structure changes isothermal titration calorimetry investigate the impact of on adenosine triphosphate (ATP) binding. Pathogenicity was further supported by enzymatic assays mass...

10.1002/ana.25524 article EN cc-by Annals of Neurology 2019-06-12

Significance Release of neurotransmitters relies on submillisecond coupling synaptic vesicle fusion to the triggering signal: AP-evoked presynaptic Ca 2+ influx. The key player that controls exocytosis is sensor synaptotagmin 1 (Syt1). While activation Syt1 has been extensively characterized, how reversibly clamps vesicular remains enigmatic. Here, using a targeted mutation combined with fluorescence imaging and electrophysiology, we show structural feature self-oligomerize provides...

10.1073/pnas.1920403117 article EN cc-by-nc-nd Proceedings of the National Academy of Sciences 2020-02-03

Significance Synaptotagmin (Syt) is the primary calcium ion (Ca 2+ ) sensor for regulated exocytosis. It couples Ca binding to soluble N -ethylmaleimide–sensitive factor attachment protein receptor-catalyzed fusion, but how this happens unclear. Here, using a targeted mutation combined with single-vesicle fusion optical assay, we show that recently discovered structural feature of Syt self-oligomerize essential coupling vesicular fusion. This suggests an elegant yet simple model in which...

10.1073/pnas.1808792115 article EN Proceedings of the National Academy of Sciences 2018-07-23

We report 2 families with undiagnosed recessive presynaptic congenital myasthenic syndrome (CMS). Whole exome or genome sequencing identified segregating homozygous variants in VAMP1: c.51_64delAGGTGGGGGTCCCC a Kuwaiti family and c.146G>C an Israeli family. VAMP1 is crucial for vesicle fusion at neuromuscular junction (NMJ). Electrodiagnostic examination showed severely low compound muscle action potentials impairment. assessed the effect of nonsense mutation on mRNA levels evaluated NMJ...

10.1002/ana.24905 article EN cc-by Annals of Neurology 2017-03-02

Previously, we showed that synaptotagmin1 (Syt1) forms Ca2+-sensitive ring-like oligomers on membranes containing acidic lipids and proposed a potential role in regulating neurotransmitter release (Zanetti et al., 2016). Here, report Syt1 assembles into similar solution when triggered by naturally occurring polyphosphates (PIP2 ATP) magnesium ions (Mg2+). These soluble rings were observed electron microscopy independently demonstrated quantified using fluorescence correlation spectroscopy....

10.7554/elife.27441 article EN cc-by eLife 2017-08-29

We report on a homozygous frameshift deletion in DDX59 (c.185del: p.Phe62fs*13) family presenting with orofaciodigital syndrome phenotype associated broad neurological involvement characterized by microcephaly, intellectual disability, epilepsy, and white matter signal abnormalities cortical subcortical ischemic events. encodes DEAD-box RNA helicase its role brain function diseases is unclear. showed reduction of mutant cDNA perturbation SHH signaling from patient-derived cell lines;...

10.1002/humu.23368 article EN Human Mutation 2017-11-11

Gamma-aminobutyric acid (GABA) and glutamate are the most abundant amino neurotransmitters in brain. GABA, an inhibitory neurotransmitter, is synthesized by glutamic decarboxylase (GAD). Its predominant isoform GAD67, contributes up to ∼90% of base-level GABA CNS, encoded GAD1 gene. Disruption results imbalance excitatory neurotransmitters, as Gad1-/- mice die neonatally severe cleft palate, it has not been possible determine any potential neurological dysfunction. Furthermore, little known...

10.1093/brain/awaa178 article EN cc-by Brain 2020-06-09

Progressive limb spasticity and cerebellar ataxia are frequently found together in clinical practice form a heterogeneous group of degenerative disorders that classified either as pure spastic or complex with additional neurological signs. Inheritance is autosomal dominant recessive. Hypomyelinating features on MRI sometimes seen ataxia, but this usually mild adults severe life limiting children. We report seven individuals an early-onset spastic-ataxia phenotype. The come from three...

10.1016/j.ajhg.2017.05.009 article EN cc-by The American Journal of Human Genetics 2017-06-01

Abstract The initial, nanometer-sized connection between the plasma membrane and a hormone- or neurotransmitter-filled vesicle –the fusion pore– can flicker open closed repeatedly before dilating resealing irreversibly. Pore dynamics determine release recycling kinetics, but pore properties are poorly known because biochemically defined single-pore assays lacking. We isolated single flickering pores connecting v-SNARE-reconstituted nanodiscs to cells ectopically expressing cognate, “flipped”...

10.1038/srep27287 article EN cc-by Scientific Reports 2016-06-06

Significance Synaptic transmission depends on all-or-none action potentials. However, subthreshold membrane potential fluctuations at the cell body spread passively along axon and affect shape of presynaptic potentials, calcium influx, neurotransmitter release. Here we apply a superresolution method to identify small terminals for patch clamp. Subthreshold modulation potentials is abolished by mutation in potassium channel Kv1.1 associated with neurological channelopathy episodic ataxia type...

10.1073/pnas.1608763114 article EN Proceedings of the National Academy of Sciences 2017-02-13

Abstract Synaptotagmin interaction with anionic lipid (phosphatidylserine/phosphatidylinositol) containing membranes, both in the absence and presence of calcium ions (Ca 2+ ), is critical to its central role orchestrating neurotransmitter release. The molecular surfaces involved, namely conserved polylysine motif C2B domain Ca -binding aliphatic loops on C2A domains, are known. Here we use surface force apparatus combined systematic mutational analysis functional directly measure...

10.1038/s41598-020-74923-y article EN cc-by Scientific Reports 2020-10-22

Cortical granule exocytosis (CGE), also known as cortical reaction, is a calcium- regulated secretion that represents membrane fusion process during meiotic cell division of oocytes. The molecular mechanism CGE still poorly understood and thought to be mediated by the SNARE pathway; nevertheless, it unkown if SNAP (acronym for soluble NSF attachment protein) N-ethilmaleimide sensitive factor), two key proteins in pathway, mediate any oocyte model. In this paper, we documented gene expression...

10.1371/journal.pone.0135679 article EN cc-by PLoS ONE 2015-08-12

Here we introduce ApoE-based nanolipoprotein particle (NLP)-a soluble, discoidal bilayer mimetic of ∼23 nm in diameter, as fusion partners to study the dynamics pores induced by SNARE proteins. Using vitro lipid mixing and content release assays, report that NLPs reconstituted with synaptic v-SNARE VAMP2 (vNLP) fuse liposomes containing cognate t-SNARE (Syntaxin1/SNAP25) partner, resulting pore opening directly external buffer. Efflux encapsulated fluorescent dextrans different sizes show...

10.1021/acs.langmuir.6b00245 article EN Langmuir 2016-03-13

Abstract Synaptotagmin1 (Syt1) synchronises neurotransmitter release to action potentials acting as the fast Ca 2+ sensor and inhibitor (clamp) of spontaneous delayed asynchronous release. Whilst Syt1 activation mechanism has been well characterised, how clamps transmitter remains enigmatic. Here we show that C2B domain-dependent oligomerisation provides molecular basis for clamping function. This follows from investigation a designed mutation (F349A), which selectively destabilises...

10.1101/594051 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2019-03-30

The population that has not received a SARS-CoV-2 vaccine is at high risk for infection whereas vaccination prevents COVID-19 severe disease, hospitalization, and death. In Argentina, to date, more than 50 million doses of vaccines against have been administered. three main applied are Sputnik V, Oxford-AstraZeneca, Sinopharm. this study, we compared the antibody response voluntary individuals day 0 (first dose day) 21-25 days post first second dose. Our results indicate after administration...

10.1016/j.heliyon.2023.e15211 article EN cc-by-nc-nd Heliyon 2023-04-19
Coming Soon ...